Xtant Medical Holdings (XTNT) Revenue Growth (1y) (2011 - 2025)
Xtant Medical Holdings (XTNT) Revenue Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.85 Bn | 176.55 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 108.55 Bn | 99.33 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 28.15 Bn | 25.87 Bn | 1.98 Bn | 7.41% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.75 Bn | 21.63 Bn | 2.07 Bn | 6.08% |
| 10 | Xtant Medical Holdings | 62.02 Mn | 44.69 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 19.04% |
| Jun 30, 2025 | 18.26% |
| Mar 31, 2025 | 18.05% |
| Dec 31, 2024 | 12.11% |
| Sep 30, 2024 | 11.66% |
| Jun 30, 2024 | 48.00% |
| Mar 31, 2024 | 55.34% |
| Dec 31, 2023 | 84.07% |
| Sep 30, 2023 | 73.00% |
| Jun 30, 2023 | 32.43% |
| Mar 31, 2023 | 38.56% |
| Dec 31, 2022 | 8.53% |
| Sep 30, 2022 | 4.97% |
| Jun 30, 2022 | 2.02% |
| Mar 31, 2022 | 3.25% |
| Dec 31, 2021 | 0.39% |
| Sep 30, 2021 | -1.71% |
| Jun 30, 2021 | 42.23% |
| Mar 31, 2021 | -14.88% |
| Dec 31, 2020 | -17.38% |